Suppr超能文献

来自正常供体的细胞毒性淋巴细胞。人类非T淋巴细胞的一种功能标志物。

Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.

作者信息

Pross H F, Jondal M

出版信息

Clin Exp Immunol. 1975 Aug;21(2):226-35.

Abstract

A phenomenon we have termed spontaneous lymphocyte-mediated cytotoxicity (SLMC) by non-thymus-derived lymphocytes from normal donors has been described. The phenomenon can be demonstrated using human and xenogeneic (mouse) cell lines as the target cell in a microplate 51Cr release assay which is simple and reproducible. In this paper, SLMC against xenogeneic targets has been evaluated as a potential marker of lumphocytotoxic function with respect to: (a) the nature of the target cell; (b) the variability of the cytotoxic function of lymphocytes from different donors, and from the same donor tested on different days; (c) the nature of the effector cell. Using buoyant density centrifugation of iron plus magnetpurified lymphocytes forming rosettes with sheep red blood cells (SRBC) (T-cells) or SRBC-rabbit 19S anti-SRBC-mouse complement (complement receptor lymphocyte), it has been demonstrated that the cytotoxic activity lies in the non-T-lymphocyte fraction, and is probably caused by the complement receptor-bearing lymphocyte. The potential usefulness of this phenomenon as a functional marker of non-T-LYMPHOCYTE CYTOTOXIC Ability, and for the assessment of serological factors ehich may affect this cytotoxicity, has been discussed.

摘要

我们已经描述了一种现象,即来自正常供体的非胸腺衍生淋巴细胞介导的自发淋巴细胞毒性(SLMC)。该现象可以在微孔板51Cr释放试验中,使用人源和异种(小鼠)细胞系作为靶细胞来证明,该试验简单且可重复。在本文中,针对异种靶标的SLMC已被评估为淋巴细胞毒性功能的潜在标志物,涉及以下方面:(a)靶细胞的性质;(b)不同供体以及同一供体在不同日期测试的淋巴细胞毒性功能的变异性;(c)效应细胞的性质。通过对与绵羊红细胞(SRBC)形成花环的铁加磁珠纯化淋巴细胞(T细胞)或SRBC-兔19S抗SRBC-小鼠补体(补体受体淋巴细胞)进行浮力密度离心,已证明细胞毒性活性存在于非T淋巴细胞部分,并且可能由携带补体受体的淋巴细胞引起。本文讨论了这种现象作为非T淋巴细胞细胞毒性能力的功能标志物以及评估可能影响这种细胞毒性的血清学因素的潜在用途。

相似文献

引用本文的文献

1
Five decades of natural killer cell discovery.自然杀伤细胞发现的五十年。
J Exp Med. 2024 Aug 5;221(8). doi: 10.1084/jem.20231222. Epub 2024 Jun 6.
2
Therapeutic approaches to enhance natural killer cell cytotoxicity.增强自然杀伤细胞细胞毒性的治疗方法。
Front Immunol. 2024 Mar 11;15:1356666. doi: 10.3389/fimmu.2024.1356666. eCollection 2024.
4
Highlights into historical and current immune interventions for cancer.癌症免疫治疗的历史和现状概述。
Int Immunopharmacol. 2023 Apr;117:109882. doi: 10.1016/j.intimp.2023.109882. Epub 2023 Feb 27.
5
Natural killer cells in sepsis: Friends or foes?脓毒症中的自然杀伤细胞:是敌是友?
Front Immunol. 2023 Jan 26;14:1101918. doi: 10.3389/fimmu.2023.1101918. eCollection 2023.
7
Natural killer cells and acute myeloid leukemia: promises and challenges.自然杀伤细胞与急性髓系白血病:前景与挑战。
Cancer Immunol Immunother. 2022 Dec;71(12):2849-2867. doi: 10.1007/s00262-022-03217-1. Epub 2022 May 31.
9
The Role of Natural Killer Cells in Autoimmune Diseases.自然杀伤细胞在自身免疫性疾病中的作用。
Front Immunol. 2021 Feb 25;12:622306. doi: 10.3389/fimmu.2021.622306. eCollection 2021.

本文引用的文献

6
Multiple sclerosis: association with HL-A3.多发性硬化症:与HL - A3的关联。
Tissue Antigens. 1972;2(1):1-4. doi: 10.1111/j.1399-0039.1972.tb00111.x.
8
HL-A antigens and multiple sclerosis.人类白细胞抗原与多发性硬化症
Tissue Antigens. 1972;2(5):405-8. doi: 10.1111/j.1399-0039.1972.tb00060.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验